<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02264483</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-EPO-2013-152</org_study_id>
    <nct_id>NCT02264483</nct_id>
  </id_info>
  <brief_title>Low-dose CT for Diagnosis of Pneumonia in COPD Exacerbations and Comparison of the Inflammatory Profile.</brief_title>
  <official_title>Assessment of the Degree of Pneumonia Underdiagnosis in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations Using Chest Low-dose Computed Tomography (CT) and Comparison of Inflammatory Profile Between the Two Entities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sociedad Española de Neumología y Cirugía Torácica</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      * Hypothesis: There is an underdiagnosis of pneumonia in COPD (Chronic Obstructive Pulmonary
      Disease) exacerbations which could be demonstrated by performing low-dose chest CT.
      Differences in the inflammatory profile in sputum and blood in patients with and without
      pneumonia can be seen.

      * Objective: To assess the degree of underdiagnosis of pneumonia in COPD exacerbations, using
      chest low-dose CT and to compare clinical and inflammatory differences in blood and sputum
      between patients with and without pneumonia.

      *Material and Methods: Prospective observational study including 75 patients with the
      diagnosis of COPD at the time of an exacerbation and with criteria for a respiratory tract
      infection. At the time of inclusion clinical features, blood and sputum analysis, chest X-ray
      and chest low-dose CT are performed. The investigators divide the patients into two groups
      according to the existence of pneumonia and the inflammatory pattern in blood (inflammatory
      markers) and sputum (cell populations and inflammatory markers) is compared between the two
      branches.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with an exacerbation of their disease who have a Pneumonia diagnosed by low dose - CT (not detected by chest X-Ray).</measure>
    <time_frame>1 year and a half</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>COPD Exacerbation</condition>
  <arm_group>
    <arm_group_label>COPD exacerbation</arm_group_label>
    <description>No intervention.
The subjects will be divided in 2 subgroups according to the image study:
COPD exacerbation with pneumonia
COPD exacerbation without pneumonia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD stable patients</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples and sputum (supernatant)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        COPD patients with an exacerbation of their disease and symptoms of respiratory infection,
        wich come to visit at outpatient pneumologic clinic.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        INCLUSION CRITERIA

          -  clinical and spirometric diagnosis of COPD.

          -  for study group: clinical symptoms of exacerbation and infection of low airway.

          -  Signed informed consent.

        EXCLUSION CRITERIA

          -  No acceptance of informed consent.

          -  The STUDY GROUP: treatment with antibiotic more tan 2 days before consultation.

          -  Another entity known pulmonology other than COPD (non-obstructive disorders,
             bronchiectasis, interstitial lung disease patients, severe pulmonary hypertension,
             hypoventilation).

          -  Chronic treatment with oral corticosteroids or immunosuppressive drug.

          -  severe organ comorbidity such as cancer in advanced or terminal phase, pulmonary
             tuberculosis with important involvement, severe pneumoconiosis.

          -  Severe alteration of nutritional status.

          -  Heart disease evolved.

          -  Limitation for understanding the study (including psychiatric disorder, language
             problem, social or cultural differences, etc.).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingrid Solanes, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Sebastian</last_name>
    <email>lsebastian@santpau.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian</last_name>
      <email>lsebastian@santpau.cat</email>
    </contact>
    <investigator>
      <last_name>Laura Sebastian, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomas Franquet, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana M Giménez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2014</study_first_submitted>
  <study_first_submitted_qc>October 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2014</study_first_posted>
  <last_update_submitted>August 28, 2015</last_update_submitted>
  <last_update_submitted_qc>August 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pneumonia in COPD exacerbation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

